National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2012 (No. 7) (No. PB 64 of 2012)

Link to law: https://www.comlaw.gov.au/Details/F2012L01783

 
PB 64 of 2012
National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2012 (No. 7)
 
National Health Act 1953
___________________________________________________________________________
 
 
I, FELICITY MCNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Amendment Instrument under subsections 100(1) and 100(2) of the National Health Act 1953.
Dated     23 August 2012
 
 
 
 
 
 
 
 
 
 
 
 
 
FELICITY MCNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
___________________________________________________________________________
 
 
 
 
1              Name of Instrument
 
(1)                This Instrument is the National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2012 (No.7).
 
(2)                This Instrument may also be cited as PB 64 of 2012.
 
2             Commencement
This Instrument commences on 1 September 2012.
3              Amendments to PB 116 of 2010
Schedule 1 amends the National Health (Highly specialised drugs program for hospitals) Special Arrangement 2010 (PB 116 of 2010).
 
 
Schedule 1                   Amendments
[1]    Schedule 1, entry for Cyclosporin in the form Capsule 25 mg with manner of administration Oral and brand Cicloral
Substitute:
 
Capsule 25 mg
Oral
Cyclosporin Sandoz
SZ
EMP
C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332
 
120
5
C
 
[2]    Schedule 1, entry for Cyclosporin in the form Capsule 50 mg with manner of administration Oral and brand Cicloral
Substitute:
 
Capsule 50 mg
Oral
Cyclosporin Sandoz
SZ
EMP
C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332
 
120
5
C
[3]    Schedule 1, entry for Cyclosporin in the form Capsule 100 mg with manner of administration Oral and brand Cicloral
Substitute:
 
Capsule 100 mg
Oral
Cyclosporin Sandoz
SZ
EMP
C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332
 
120
5
C
[4]    Schedule 1, after entry for Lamivudine in the form of Tablet 100 mg with manner of administration Oral and brand Zeffix
insert:
 
 
 
Zetlam
AF
EMP
C3959 C3960 C3961 C3962
 
56
5
D
 
[5]    Schedule 1, after entry for Lamivudine in the form of Tablet 150 mg with manner of administration Oral and brand Lamivudine RBX
insert:
 
 
 
Alphapharm Lamivudine
AF
EMP
C3586 C3587 C3588 C3589
 
120
5
D
 
[6]    Schedule 1, after entry for Lamivudine in the form of Tablet 300 mg with manner of administration Oral and brand Lamivudine RBX
insert:
 
 
 
Alphapharm Lamivudine
AF
EMP
C3586 C3587 C3588 C3589
 
60
5
D
 
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.
Read Entire Law on www.comlaw.gov.au